dc.contributor.author | Direskeneli, H | |
dc.contributor.author | Yurdakul, Sebahattin | |
dc.contributor.author | Akoglu, T | |
dc.contributor.author | Tokay, S | |
dc.date.accessioned | 2021-03-03T13:36:37Z | |
dc.date.available | 2021-03-03T13:36:37Z | |
dc.date.issued | 2001 | |
dc.identifier.citation | Tokay S., Direskeneli H., Yurdakul S., Akoglu T., "Anticardiolipin antibodies in Behcet's disease: a reassessment", RHEUMATOLOGY, cilt.40, sa.2, ss.192-195, 2001 | |
dc.identifier.issn | 1462-0324 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_34f8a5da-0341-4b4f-b78f-622e772862a3 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/39819 | |
dc.identifier.uri | https://doi.org/10.1093/rheumatology/40.2.192 | |
dc.description.abstract | Objective. To assess the frequency and clinical relevance of anticardiolipin antibodies (aCL) in Behcet's disease (BD). | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | İmmünoloji ve Romatoloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ROMATOLOJİ | |
dc.title | Anticardiolipin antibodies in Behcet's disease: a reassessment | |
dc.type | Makale | |
dc.relation.journal | RHEUMATOLOGY | |
dc.contributor.department | , , | |
dc.identifier.volume | 40 | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 192 | |
dc.identifier.endpage | 195 | |
dc.contributor.firstauthorID | 8676 | |